Skip to main content
CSL Ltd. logo

CSL Ltd. — Investor Relations & Filings

Ticker · CSL ISIN · AU000000CSL8 LEI · 529900ECSECK5ZDQTE14 ASX Manufacturing
Filings indexed 2,545 across all filing types
Latest filing 2025-10-28 Regulatory Filings
Country AU Australia
Listing ASX CSL

About CSL Ltd.

https://www.csl.com/

CSL is a global biotechnology company that researches, develops, manufactures, and markets a diverse portfolio of medicines. The company operates through distinct business units. CSL Behring provides plasma-derived and recombinant biotherapies for patients with rare and serious diseases, including bleeding disorders, immunodeficiencies, and neurological disorders. CSL Seqirus is a leading provider of vaccines, with a focus on influenza prevention and public health. CSL Vifor specializes in therapies for iron deficiency and nephrology, addressing the full spectrum of kidney disease. Collectively, CSL delivers lifesaving and life-enhancing treatments to a global patient population.

Recent filings

Filing Released Lang Actions
Final Director's Interest Notice 2 pages 223.8KB
Regulatory Filings
2025-10-28 English
CSL wurde von der International Society for Pharmaceutical Engineering (ISPE) als Gesamtsieger der 2025 Facility of the Year Awards" ausgezeichnet
Environmental & Social Information Classification · 1% confidence The document is a press release announcing that CSL received an industry award ('Facility of the Year Award') from the ISPE. It does not contain financial statements, regulatory filings, or specific corporate governance reports. As it is a general corporate news announcement that does not fit into the specialized categories like 10-K, ER, or MANG, it falls under the 'Regulatory Filings' (RNS) category as a general corporate announcement.
2025-10-28 German
CSL 2025 AGM Chair and CEO Speech and Presentation 41 pages 4.7MB
Regulatory Filings
2025-10-27 English
Results of Meeting 2 pages 376.6KB
Regulatory Filings
2025-10-27 English
CSL Honoured as Overall Winner of the 2025 Facility of the Year Awards by the International Society for Pharmaceutical Engineering (ISPE)
Regulatory Filings Classification · 1% confidence The document is a press release announcing that CSL has won the '2025 Facility of the Year Award' from the ISPE. It is a corporate news announcement regarding operational recognition and does not fit into specific financial reporting categories like 10-K, ER, or IR. As it is a general corporate announcement disseminated via a news service (EQS), it falls under the 'Regulatory Filings' (RNS) category as the fallback for miscellaneous corporate news.
2025-10-27 English
Update - Notification of buy-back - CSL 5 pages 15.9KB
Regulatory Filings
2025-10-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.